Skip to content

Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty

Risk of Dementia and Heart Failure in Total Joint Arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04166539
Enrollment
115
Registered
2019-11-18
Start date
2019-10-01
Completion date
2021-09-27
Last updated
2021-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metallosis, Pain, Total Hip Replacement, Total Knee Replacement

Keywords

Revision Surgery, Hip, Knee, Metals, Metallosis, Toxicity

Brief summary

The purpose of this research is to understand whether patients who previously had total hip or total knee replacement experience memory, thinking or heart problems. This study will help us determine if and how often these problems occur.

Detailed description

At your first visit you will be asked to do the following. * Sign this informed consent document. * Questionnaire: You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities. * Interview: The interview will be performed by the study coordinator who is a member of the research team. It will take about 20-30 minutes to complete. You will be asked to answer questions about your general health, surgeries, medications, and your memory and thinking skills. * Memory Interview: You will have an evaluation of your memory and thinking skills. You will answer questions and perform tasks that evaluate various thinking abilities such as concentration, memory, reasoning, and learning. * Blood draw: Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests. * Magnetic Resonance Imaging (MRI) of your brain (optional): If you agree to participate, you will be asked to have MR imaging of your brain. * Echocardiogram: You will be asked to have an echocardiogram of your heart. * Follow-up visit in 2-3 years: You will be asked to return to Mayo for your second study visit in 2-3 years. At this visit, you will be asked to complete the same memory and thinking tests described for the first visit. You will also be asked to repeat the echocardiogram.

Interventions

BEHAVIORALQuestionnaires

You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities.

BEHAVIORALInterviews

Behavioral and Memory interviews will take place with the patient.

OTHERBlood draw

Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests.

RADIATIONMagnetic Resonance Imaging

Each MR examination takes about 45 minutes and does not require the use of needles, medication or contrast enhancement. You will lie on your back and enter the MR scanner for the study, during which time you will hear knocking noises. People with pacemakers, aneurysm clips, cochlear implants, or metal/foreign objects in their eyes are not permitted to undergo MR studies. We will review your implants and determine your eligibility.

DIAGNOSTIC_TESTEchocardiogram

Each echocardiogram takes about 30 minutes. This test uses sound waves to look at your heart. The person doing the test will press on your chest with a machine to obtain the pictures. The pressure may be uncomfortable. The echocardiogram will involve an image enhancement agent infusion to obtain better images.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient is willing to sign consent * Patients scheduled for revision surgery for osteolysis, aseptic loosening, or wear of TJA implants/ALTR. OR -MCSA (Mayo Clinic Study of Aging) patients with THA or TKA with at least 10 years since surgery.

Exclusion criteria

* History of dementia * History of cardiomyopathy or heart failure * Revision for infection or fracture * Patient is pregnant * Patient has medication patches on * Patient has a pacemaker or defibrillator (ICD) * Patient has a deep brain stimulator (DBS) * Patient has a vagal neuro stimulator (VNS) * Patient has any other kind of neuro stimulator * Patient has aneurysm clips in their head * Patient has a tissue expander * Patient has had a gastrointestinal clip or pill camera inserted in the last 90 days * Patient has an esophageal reflux management system (LINX) * Patient has a cochlear (ear) or auditory implant * Patient has any implanted device (electronic or not) with magnets * Patient has an eye injury involving metal * Patient has allergy to contrast or dye

Design outcomes

Primary

MeasureTime frameDescription
Mild Cognitive Impairment1 yearCognitive impairment as assessed through interviews
Brain MRI findings1 yearimaging
Left ventricular dysfunction1 yearheart dysfunction as assessed using echocardiography

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026